The regulatory subunit of cAMP-dependent protein kinase as a target for chemotherapy of cancer and other cellular dysfunctional-related diseases

This publication has 82 references indexed in Scilit:

• Role of site-selective cAMP analogs in the control and reversal of malignancy
  Pharmacology & Therapeutics, 1991
• Suppression of malignancy targeting the intracellular signal transducing proteins of cAMP: The use of site-selective cAMP analogs, antisense strategy, and gene transfer
  Life Sciences, 1991
• Cooperative effect of 8-Cl-cAMP and rhGM-CSF on the differentiation of HL-60 human leukemia cells
  Biochemical and Biophysical Research Communications, 1991
• Phosphorylation-induced binding and transcriptional efficacy of nuclear factor CREB
  Nature, 1988
• Differentiation-associated increase of cAMP-dependent type II protein kinase in a murine preadipose cell line (ST 13)
  Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1985
• cAMP Receptor Proteins and protein Kinases in Human Lymphocytes: Fundamental Alterations in Chronic Lymphocytic Leukemia Cells
  European Journal of Biochemistry, 1981
• On the interaction of cyclic amp-binding protein and estrogen receptor in growth control
  Life Sciences, 1979
• Evidence that rabbit muscle protein kinase has two kinetically distinct binding sites for adenosine 3′; 5′-cyclic monophosphate
  Biochemical and Biophysical Research Communications, 1978
• Cyclic-AMP binding sites on the cell surface of thymic lymphocytes
  Life Sciences, 1972
• THE PROPERTIES OF AN ADENINE RIBONUCLEOTIDE PRODUCED WITH CELLULAR PARTICLES, ATP, Mg⁺⁺, AND EPINEPHRINE OR GLUCAGON
  Journal of the American Chemical Society, 1957